Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020

M. Bellone; A. Brevi; V. Bronte; S. Dusi; P. F. Ferrucci; P. Nistico; A. Rosato; V. Russo; Antonio SICA; G. Toietta; M. P. Colombo

doi:10.1007/s00262-022-03145-0

Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020

M. Bellone, A. Brevi, V. Bronte, S. Dusi, P. F. Ferrucci, P. Nistico, A. Rosato, V. Russo, Antonio SICA, G. Toietta, M. P. Colombo

Dipartimento di Scienze del Farmaco

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
Rivista	Cancer Immunology, Immunotherapy
DOI	https://doi.org/10.1007/s00262-022-03145-0
Stato di pubblicazione	Pubblicato - 2022

Keywords

Adoptive immunotherapy
Cancer vaccines
Checkpoint blockade agents
Immunotherapy
NIBIT
Targeted therapies

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1007/s00262-022-03145-0

https://hdl.handle.net/11579/145940

Altri file e collegamenti

handle

Cita questo

@article{63da5db462d44ed291a2f564519563de,

title = "Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020",

keywords = "Adoptive immunotherapy, Cancer vaccines, Checkpoint blockade agents, Immunotherapy, NIBIT, Targeted therapies, Adoptive immunotherapy, Cancer vaccines, Checkpoint blockade agents, Immunotherapy, NIBIT, Targeted therapies",

author = "M. Bellone and A. Brevi and V. Bronte and S. Dusi and Ferrucci, {P. F.} and P. Nistico and A. Rosato and V. Russo and Antonio SICA and G. Toietta and Colombo, {M. P.}",

year = "2022",

doi = "10.1007/s00262-022-03145-0",

language = "English",

journal = "Cancer Immunology, Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020

AU - Bellone, M.

AU - Brevi, A.

AU - Bronte, V.

AU - Dusi, S.

AU - Ferrucci, P. F.

AU - Nistico, P.

AU - Rosato, A.

AU - Russo, V.

AU - SICA, Antonio

AU - Toietta, G.

AU - Colombo, M. P.

PY - 2022

Y1 - 2022

KW - Adoptive immunotherapy

KW - Cancer vaccines

KW - Checkpoint blockade agents

KW - Immunotherapy

KW - NIBIT

KW - Targeted therapies

KW - Adoptive immunotherapy

KW - Cancer vaccines

KW - Checkpoint blockade agents

KW - Immunotherapy

KW - NIBIT

KW - Targeted therapies

UR - https://iris.uniupo.it/handle/11579/145940

U2 - 10.1007/s00262-022-03145-0

DO - 10.1007/s00262-022-03145-0

M3 - Article

SN - 0340-7004

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

ER -